An Open-label, Three-centre, Randomised, Two-period, Crossover Study to Assess the Efficacy, Safety and Utility of Overnight Closed-loop in Comparison With CGM Alone in the Home Setting in Children and Adolescents With Type 1 Diabetes
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 03 Mar 2017 Biomarkers information updated
- 17 Dec 2013 Planned end date changed from 1 Mar 2015 to 1 May 2015 as reported by ClinicalTrials.gov.
- 01 Dec 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.